Tags:AnalyticsAssistedBusinessFinTechHealthTechIndustryMarketMedtechServiceUniversity
VascVersa is new Regenerative Medicine company recently spun out from Queen's University in Belfast. ​Our Vision is to commercialise living medicines to reinvigorate patients lives. Utilising Angicyte technology we are developing new cell therapies for vascular regeneration.
Location: United Kingdom, Northern Ireland, Belfast
Member count: 1-10
Total raised: $7.009885M
Founded date: 2018

Investors 1

DateNameWebsite
19.05.2022Clarendon ...clarendon-...

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
12.08.2022Series A$6.405585M--
07.08.2022Seed$604.3K--

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
24.08.2022Cell Thera...Cell Therapy Processing Market...--einpresswi...
08.08.2022Cell Thera...Bengaluru-based cell therapy c...--thestartup...
08.08.2022Cell thera...ETtech(L to R) Dr Rajarshi Pal...--economicti...
25.10.2021Juventas C...Juventas has grabbed a $63 mil...Biotech-fiercebiot...
23.06.2021Abata hope...After three and a half years o...Biotech-fiercebiot...
-Temasek-ba...InvestmentsNews Qishin Tariq ...--techinasia...
-Cell thera...Eyestem, a Bengaluru-based cel...CompaniesIsha Raute...thehindubu...